SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-005736
Filing Date
2023-02-21
Accepted
2023-02-21 19:01:31
Documents
2
Period of Report
2023-02-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5927
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4731
  Complete submission text file 0000899243-23-005736.txt   12241
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Issuer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CULLINAN MANAGEMENT, INC. ONE MAIN STREET, SUTIE 520 CAMBRIDGE MA 02142
Business Address
Trigilio Jeffrey (Reporting) CIK: 0001838671 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39856 | Film No.: 23650043